Arthur E. Brown is Co-Chair of Kaye Scholer’s Product Liability Group, and a member of the firm’s Complex Commercial Litigation Group. His practice focuses on representing and advising clients on mass tort and product liability issues, investigations by federal and state authorities, inquiries from Congress, and commercial litigation disputes. As part of his practice, Arthur frequently serves as national counsel representing pharmaceutical companies in mass tort product liability actions, advises clients on strategic litigation and settlement decisions in the areas of commercial litigation and white collar investigations, and counsels clients on litigation avoidance.MEHR
Arthur was co-lead national coordinating counsel for AstraZeneca in thousands of product liability lawsuits alleging that its atypical antipsychotic drug, Seroquel, causes diabetes and related injuries. He has also served as regional counsel defending AstraZeneca against product liability cases alleging that its anesthetic, administered via a shoulder pain pump, caused chondrolysis (loss of cartilage). In addition, Arthur was part of the Kaye Scholer team that served as national trial counsel to Pfizer and Novartis regarding both prescription and over-the-counter pharmaceutical products.
Arthur is also an experienced commercial litigator. For example, he successfully advised AstraZeneca in a breach of contract claim brought by Verus Pharmaceuticals stemming from an alleged breach of a Collaboration Agreement to develop a pediatric asthma treatment. The case was dismissed on pretrial motion and the dismissal was upheld on appeal. He has also assisted and defended pharmaceutical companies in government and Congressional investigations related to marketed medicines. Most recently, Arthur joined the team defending former members of AIG’s senior management in a complex fraud action brought by the New York Attorney General’s office under the Martin Act
In 2013, Arthur’s group was ranked as a top tier practice by Chambers USA, and clients noted that the group is “incredibly creative and receptive. The product result is absolutely perfect and they tend to be very strategic.” The group was also recognized by Chambers as “Recommended for Client Service” and “Recommended for Commercial Awareness.” The Legal 500 USA 2013 ranks Kaye Scholer’s Product Liability group in Tier 1. Arthur was also a part of the Kaye Scholer team that was awarded Product Liability Firm of the Year at the 2008 Chambers and Partners “USA Awards for Excellence” ceremony.
Arthur has also been individually acknowledged for his impressive work and was most recently recognized in Chambers USA 2013 as a Leading Lawyer in Product Liability & Mass Torts. Arthur is described by clients as “smart, practical and incredibly strategic.” He is also recommended by The Legal 500 United States 2013 for his work in Product Liability and Mass Tort Defense – Pharmaceuticals and Medical Devices. In 2012, Arthur was named a “Life Science Star” in the inaugural issue of Euromoney’s LMG Life Sciences Guide.
For several years, Arthur was part of a national counsel team representing a number of asbestos manufacturers in nationwide litigation in both federal and state courts. In addition, he has defended construction companies in catastrophic injury cases arising from construction accidents and toxic exposures.
From 1994 to 1997, Arthur served as an Assistant District Attorney in the New York County District Attorney’s office, where he prosecuted a wide range of cases involving street crime, conspiracy, fraud and embezzlement.